Losartan does not reduce lung injury in hospitalized COVID-19 patients
Administration of losartan to hospitalized patients with COVID-19 and acute lung injury is not efficacious for reducing lung injury, according to a study published online March 16 in JAMA Network Open.
Mar 16, 2022
0
49